• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Stargardt 病患者 12 个月内固视位置和稳定性的纵向变化:ProgStar 报告第 12 号。

Longitudinal Changes of Fixation Location and Stability Within 12 Months in Stargardt Disease: ProgStar Report No. 12.

机构信息

Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, USA; Department of Ophthalmology and Visual Sciences, Case Western Reserve University, Cleveland, Ohio, USA.

Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, USA; Department of Ophthalmology, Medical University, Graz, Austria; Moorfields Eye Hospital, London, UK; Department of Ophthalmology, Johannes Kepler University, Linz, Austria.

出版信息

Am J Ophthalmol. 2018 Sep;193:54-61. doi: 10.1016/j.ajo.2018.06.003. Epub 2018 Jun 8.

DOI:10.1016/j.ajo.2018.06.003
PMID:29890160
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7083180/
Abstract

PURPOSE

To investigate the natural history of Stargardt disease (STGD1) using fixation location and fixation stability.

DESIGN

Multicenter, international, prospective cohort study.

METHODS

Fixation testing was performed using the Nidek MP-1 microperimeter as part of the prospective, multicenter, natural history study on the Progression of Stargardt disease (ProgStar). A total of 238 patients with ABCA4-related STGD1 were enrolled at baseline (bilateral enrollment in 86.6%) and underwent repeat testing at months 6 and 12.

RESULTS

Outcome measures included the distance of the preferred retinal locus from the fovea (PRL) and the bivariate contour ellipse area (BCEA). After 12 months of follow-up, the change in the eccentricity of the PRL from the anatomic fovea was -0.0014 degrees (95% confidence interval [CI], -0.27 degrees, 0.27 degrees; P = .99). The deterioration in the stability of fixation as expressed by a larger BCEA encompassing 1 standard deviation of all fixation points was 1.21 degrees squared (deg) (95% CI, -1.23 deg, 3.65 deg; P = .33). Eyes with increases and decreases in PRL eccentricity and/or BCEA values were observed.

CONCLUSIONS

Our observations point to the complexity of fixation parameters. The association of increasingly eccentric and unstable fixation with longer disease duration that is typically found in cross-sectional studies may be countered within individual patients by poorly understood processes like neuronal adaptation. Nevertheless, fixation parameters may serve as useful secondary outcome parameters in selected cases and for counseling patients to explain changes to their visual functionality.

摘要

目的

通过固视位置和固视稳定性研究斯塔加特病(STGD1)的自然史。

设计

多中心、国际、前瞻性队列研究。

方法

固视测试使用 Nidek MP-1 微视野计进行,作为前瞻性、多中心斯塔加特病进展(ProgStar)自然史研究的一部分。共有 238 名 ABCA4 相关 STGD1 患者在基线时入组(86.6%为双侧入组),并在 6 个月和 12 个月时进行重复测试。

结果

主要观察指标包括视网膜优势位置与黄斑中心凹的距离(PRL)和双变量轮廓椭圆面积(BCEA)。在 12 个月的随访后,PRL 从解剖性黄斑中心凹的偏心率变化为-0.0014 度(95%置信区间[CI],-0.27 度,0.27 度;P=.99)。固视稳定性的恶化表现为 BCEA 增大,包含所有固视点的 1 个标准差,为 1.21 度平方(deg)(95%CI,-1.23 deg,3.65 deg;P=.33)。观察到 PRL 偏心率和/或 BCEA 值增加和减少的眼睛。

结论

我们的观察结果表明固视参数的复杂性。在横断面研究中,通常发现与疾病持续时间较长相关的越来越偏心和不稳定的固视与在个体患者中由神经元适应等尚未充分了解的过程相抵消。然而,固视参数在某些情况下可能作为有用的次要结局参数,并为解释患者视觉功能变化提供依据。

相似文献

1
Longitudinal Changes of Fixation Location and Stability Within 12 Months in Stargardt Disease: ProgStar Report No. 12.Stargardt 病患者 12 个月内固视位置和稳定性的纵向变化:ProgStar 报告第 12 号。
Am J Ophthalmol. 2018 Sep;193:54-61. doi: 10.1016/j.ajo.2018.06.003. Epub 2018 Jun 8.
2
Fixation Location and Stability Using the MP-1 Microperimeter in Stargardt Disease: ProgStar Report No. 3.使用MP-1微视野计在Stargardt病中的固视位置与稳定性:ProgStar报告第3号
Ophthalmol Retina. 2017 Jan-Feb;1(1):68-76. doi: 10.1016/j.oret.2016.08.009. Epub 2016 Oct 31.
3
Macular Sensitivity Measured With Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 7.在斯塔加特病萎缩进展期斯塔加特病(ProgStar)研究中使用微视野计测量黄斑敏感性:第7号报告。
JAMA Ophthalmol. 2017 Jul 1;135(7):696-703. doi: 10.1001/jamaophthalmol.2017.1162.
4
Functional changes at the preferred retinal locus in subjects with bilateral central vision loss.双侧中心视力丧失患者视网膜偏好位点的功能变化。
Graefes Arch Clin Exp Ophthalmol. 2018 Jan;256(1):29-37. doi: 10.1007/s00417-017-3818-3. Epub 2017 Oct 2.
5
Metrics and Acquisition Modes for Fixation Stability as a Visual Function Biomarker.作为视觉功能生物标志物的固定稳定性的指标和采集模式。
Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO268-BIO276. doi: 10.1167/iovs.17-21710.
6
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.《继发于斯塔加特病的萎缩自然史(ProgStar)研究:设计与基线特征》:ProgStar 报告第 1 号。
Ophthalmology. 2016 Apr;123(4):817-28. doi: 10.1016/j.ophtha.2015.12.009. Epub 2016 Jan 16.
7
The Effect of Attention on Fixation Stability During Dynamic Fixation Testing in Stargardt Disease.注意对斯塔加特病患者动态固视测试中固视稳定性的影响。
Am J Ophthalmol. 2020 Sep;217:305-316. doi: 10.1016/j.ajo.2020.05.002. Epub 2020 May 11.
8
Characteristics of the preferred retinal loci of better and worse seeing eyes of patients with a central scotoma.中心暗点患者视力较好和较差眼睛的优势视网膜位点特征。
Can J Ophthalmol. 2016 Oct;51(5):362-367. doi: 10.1016/j.jcjo.2016.01.007. Epub 2016 Apr 23.
9
Longitudinal Changes of Fixation Stability and Location Within 24 Months in Stargardt Disease: ProgStar Report No. 16.Stargardt病24个月内固定稳定性和位置的纵向变化:ProgStar报告第16号
Am J Ophthalmol. 2022 Jan;233:78-89. doi: 10.1016/j.ajo.2021.07.013. Epub 2021 Jul 21.
10
Effectiveness of Low Vision Rehabilitation Using Microperimetric Acoustic Biofeedback Training in Patients with Central Scotoma.使用微视野声生物反馈训练治疗中心性暗点患者的低视力康复效果。
Curr Eye Res. 2021 May;46(5):731-738. doi: 10.1080/02713683.2020.1833348. Epub 2020 Oct 18.

引用本文的文献

1
Advances in machine learning for ABCA4-related retinopathy: segmentation and phenotyping.用于ABCA4相关视网膜病变的机器学习进展:分割与表型分析。
Int Ophthalmol. 2025 Jul 23;45(1):314. doi: 10.1007/s10792-025-03690-4.
2
High Resolution Imaging and Fixation Analysis of Eccentric Preferred Retinal Loci in Macular Diseases.黄斑疾病中偏心优势视网膜位点的高分辨率成像与固定分析
Invest Ophthalmol Vis Sci. 2025 May 1;66(5):18. doi: 10.1167/iovs.66.5.18.
3
The role of multimodal imaging and vision function testing in -related retinopathies and their relevance to future therapeutic interventions.

本文引用的文献

1
Progression of Visual Acuity and Fundus Autofluorescence in Recent-Onset Stargardt Disease: ProgStar Study Report #4.新近发病的Stargardt病患者的视力和眼底自发荧光进展:ProgStar研究报告#4
Ophthalmol Retina. 2017 Nov-Dec;1(6):514-523. doi: 10.1016/j.oret.2017.02.008. Epub 2017 Apr 28.
2
Fixation Location and Stability Using the MP-1 Microperimeter in Stargardt Disease: ProgStar Report No. 3.使用MP-1微视野计在Stargardt病中的固视位置与稳定性:ProgStar报告第3号
Ophthalmol Retina. 2017 Jan-Feb;1(1):68-76. doi: 10.1016/j.oret.2016.08.009. Epub 2016 Oct 31.
3
Visual Acuity Change over 12 Months in the Prospective Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: ProgStar Report Number 6.
多模态成像和视觉功能测试在相关视网膜病变中的作用及其与未来治疗干预的相关性。
Ther Adv Ophthalmol. 2021 Dec 19;13:25158414211056384. doi: 10.1177/25158414211056384. eCollection 2021 Jan-Dec.
4
Clinical Perspectives and Trends: Microperimetry as a Trial Endpoint in Retinal Disease.临床观点与趋势:微视野计在视网膜疾病中的试验终点应用。
Ophthalmologica. 2021;244(5):418-450. doi: 10.1159/000515148. Epub 2021 Feb 10.
5
Orientation of the preferred retinal locus (PRL) is maintained following changes in simulated scotoma size.在模拟的暗点大小发生变化后,优势视网膜点(PRL)的方位保持不变。
J Vis. 2020 Jul 1;20(7):25. doi: 10.1167/jov.20.7.25.
6
Analysis of retinal sublayer thicknesses and rates of change in ABCA4-associated Stargardt disease.ABCA4 相关性渗出性年龄相关性黄斑变性的视网膜各层厚度分析及变化率。
Sci Rep. 2020 Oct 6;10(1):16576. doi: 10.1038/s41598-020-73645-5.
7
Effect of Disease Progression on the PRL Location in Patients With Bilateral Central Vision Loss.疾病进展对双侧中心视力丧失患者 PRL 定位的影响。
Transl Vis Sci Technol. 2020 Jul 30;9(8):47. doi: 10.1167/tvst.9.8.47. eCollection 2020 Jul.
8
Longitudinal Microperimetric Changes of Macular Sensitivity in Stargardt Disease After 12 Months: ProgStar Report No. 13.《Stargardt 病患者黄斑敏感性在 12 个月后的纵向微视野计变化:ProgStar 报告 No.13》。
JAMA Ophthalmol. 2020 Jul 1;138(7):772-779. doi: 10.1001/jamaophthalmol.2020.1735.
9
Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations.由 ABCA4 突变引起的视网膜疾病的临床谱、遗传复杂性和治疗方法。
Prog Retin Eye Res. 2020 Nov;79:100861. doi: 10.1016/j.preteyeres.2020.100861. Epub 2020 Apr 9.
10
Comparison of Fundus-Guided Microperimetry and Multifocal Electroretinography for Evaluating Hydroxychloroquine Maculopathy.用于评估羟氯喹黄斑病变的眼底引导微视野检查与多焦视网膜电图的比较
Transl Vis Sci Technol. 2019 Sep 27;8(5):19. doi: 10.1167/tvst.8.5.19. eCollection 2019 Sep.
12 个月内 Stargardt 病相关萎缩的前瞻性进展(ProgStar)研究中视力的变化:ProgStar 报告第 6 号。
Ophthalmology. 2017 Nov;124(11):1640-1651. doi: 10.1016/j.ophtha.2017.04.026. Epub 2017 May 23.
4
Incidence of Atrophic Lesions in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 5.斯塔加特病萎缩进展研究(ProgStar)中斯塔加特病萎缩性病变的发生率:第5号报告
JAMA Ophthalmol. 2017 Jul 1;135(7):687-695. doi: 10.1001/jamaophthalmol.2017.1121.
5
Macular Sensitivity Measured With Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 7.在斯塔加特病萎缩进展期斯塔加特病(ProgStar)研究中使用微视野计测量黄斑敏感性:第7号报告。
JAMA Ophthalmol. 2017 Jul 1;135(7):696-703. doi: 10.1001/jamaophthalmol.2017.1162.
6
Emerging therapies for inherited retinal degeneration.遗传性视网膜变性的新兴疗法。
Sci Transl Med. 2016 Dec 7;8(368):368rv6. doi: 10.1126/scitranslmed.aaf2838.
7
Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options.斯塔加特病:临床特征、分子遗传学、动物模型及治疗选择
Br J Ophthalmol. 2017 Jan;101(1):25-30. doi: 10.1136/bjophthalmol-2016-308823. Epub 2016 Aug 4.
8
Visual Acuity Loss and Associated Risk Factors in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 2).《斯塔加特病回顾性进展研究(ProgStar 报告 2 号)中的视力丧失及相关危险因素》。
Ophthalmology. 2016 Sep;123(9):1887-97. doi: 10.1016/j.ophtha.2016.05.027. Epub 2016 Jul 2.
9
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.《继发于斯塔加特病的萎缩自然史(ProgStar)研究:设计与基线特征》:ProgStar 报告第 1 号。
Ophthalmology. 2016 Apr;123(4):817-28. doi: 10.1016/j.ophtha.2015.12.009. Epub 2016 Jan 16.
10
Repeatability of Nidek MP-1 Fixation Measurements in Patients With Bilateral Central Field Loss.双侧中心视野缺损患者中尼德克MP-1固定测量的可重复性
Invest Ophthalmol Vis Sci. 2015 Apr;56(4):2624-30. doi: 10.1167/iovs.15-16511.